Remarkably, VAX1 and LMX1A methylation were more frequently detected in urine samples from recurrent bladder cancer patients as compared to that of newly diagnosed bladder cancer patients, thus suggesting that the methylation of VAX1 and LMX1A was associated with bladder cancer recurrence. This evidence concerns the gene LMX1A and urinary bladder cancer.